Bioelectronics Corp

Company Profile

Bioelectronics Corp had its IPO on under the ticker symbol BIEL.

The company operates in the Healthcare sector and Medical Devices industry. Bioelectronics Corp has a staff strength of 0 employees.

Stock update

Shares of Bioelectronics Corp opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a -25% slip from the previous day's closing price.

A total volume of 29,396,740 shares were traded at the close of the day’s session.

In the last one week, shares of Bioelectronics Corp have slipped by -40%.

Bioelectronics Corp's Key Ratios

Bioelectronics Corp has a market cap of $12.35 million, indicating a price to book ratio of 0 and a price to sales ratio of 30.732.

In the last 12-months Bioelectronics Corp’s revenue was $1.61 million with a gross profit of $795532 and an EBITDA of $-1364449. The EBITDA ratio measures Bioelectronics Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bioelectronics Corp’s operating margin was -8.52% while its return on assets stood at -33.67% with a return of equity of 0%.

In Q4, Bioelectronics Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 65.1%.

Bioelectronics Corp’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bioelectronics Corp’s profitability.

Bioelectronics Corp stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 30.732.

Bioelectronics Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0

Total Liabilities

$5.93 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Bioelectronics Corp ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Bioelectronics Corp ended 2024 with $0 in deferred long-term liabilities, $5.93 million in other current liabilities, 24378829.00 in common stock, $-38306477.00 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Bioelectronics Corp’s total current assets stands at $83886.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $57699.00 compared to accounts payable of $647844.00 and inventory worth $25262.00.

In 2024, Bioelectronics Corp's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Bioelectronics Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0

52-Week High

$0.0012

52-Week Low

$0.0003

Analyst Target Price

$

Bioelectronics Corp stock is currently trading at $0 per share. It touched a 52-week high of $0.0012 and a 52-week low of $0.0012. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0.4% are held by institutions.